Janssen R&D
Spring House, PA, United States
Dr. Hao is a molecular biologist who has worked in the Immunology Biotech and Pharma environment for many years. He brings translational biology mindset as biomarker lead on several early to mid stage clinical trials with him and is currently focusing on early Discovery space.
0074: Distinct PD-1 Receptor Engagement Leads to Different Pharmacodynamic Effects
Sunday, November 12, 2023
9:00 AM – 11:00 AM PT
Disclosure information not submitted.
